Search results
Results from the WOW.Com Content Network
Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). [11] It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. [11]
This set an initial foundation for the developing theory of attachment as involving a two-pattern model, security vs insecurity, centered on safety and play. However, throughout the 1950s, both Ainsworth and Bowlby began developing a three-pattern model centered on danger and survival. [ 4 ]
The Maudsley is the largest mental health training institution in the UK. It is part of South London and Maudsley NHS Foundation Trust, and works in partnership with the Institute of Psychiatry, King's College London. [1] The hospital was one of the originating institutions in producing the Maudsley Prescribing Guidelines.
Before becoming a foundation trust in 2004, the trust received top 3-star rating in the former national performance charts. [16] In 2016, the CQC rated the hospital as requiring improvement. [17] The Trust lost the contract for sexual health services when Cheshire West and Chester Council awarded it to East Cheshire NHS Trust in December 2014. [18]
The Queen Elizabeth Hospital Birmingham is a major, 1,215 bed, tertiary NHS and military hospital in the Edgbaston area of Birmingham, situated very close to the University of Birmingham. The hospital, which cost £545 million to construct, opened on 16 June 2010, replacing the previous Queen Elizabeth Hospital and Selly Oak Hospital .
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes , which help keep the bite area unclotted long enough for the animal to obtain blood.
For premium support please call: 800-290-4726 more ways to reach us
The trust is under the leadership of Chair Dame Yve Buckland and chief executive Jonathan Brotherton [1] On 30 June 2004, the Trust received authorisation to become one of the first NHS Foundation Trusts in England, under the leadership of ex-chief executive Dame Julie Moore, who succeeded Mark Britnell. [2]